Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Autor: Jagannath, Sundar, Heffner, Leonard T., Jr., Ailawadhi, Sikander, Munshi, Nikhil C., Zimmerman, Todd M., Rosenblatt, Jacalyn, Lonial, Sagar, Chanan-Khan, Asher, Ruehle, Markus, Rharbaoui, Faiza, Haeder, Thomas, Wartenberg-Demand, Andrea, Anderson, Kenneth C.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia June 2019 19(6):372-380
Databáze: ScienceDirect